======= DPH2 ======= == Gene Information == * **Official Symbol**: DPH2 * **Official Name**: diphthamide biosynthesis 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1802|1802]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BQC3|Q9BQC3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DPH2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DPH2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603456|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Required for the first step in the synthesis of diphthamide, a post-translational modification of histidine which occurs in translation elongation factor 2 (EEF2). {ECO:0000250|UniProtKB:Q9CR25}. |Diphthamide syn| |2-(3-amino-3-carboxypropyl)histidine synthase activity| |peptidyl-diphthamide biosynthetic process from peptidyl-histidine| |peptidyl-diphthamide metabolic process| |regulation of cytoplasmic translational elongation| |peptidyl-histidine modification| |regulation of translational elongation| |regulation of cytoplasmic translation| |regulation of translation| |regulation of cellular amide metabolic process| |posttranscriptional regulation of gene expression| |peptidyl-amino acid modification| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-2.84| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-2.69| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-2.51| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-2.5| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|-2.42| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.11| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|-2.08| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-1.91| |[[:results:exp19|Etoposide 1μM R00 exp19]]|-1.84| |[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|-1.82| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-1.82| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-1.79| |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-1.75| |[[:results:exp31|Rifampicin 1μM R00 exp31]]|-1.74| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|1.7| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|1.77| |[[:results:exp359|FK-506 30μM R07 exp359]]|1.83| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|1.89| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|2.51| |[[:results:exp275|Citral 75μM R06 exp275]]|2.76| |[[:results:exp274|Citral 50μM R06 exp274]]|2.99| |[[:results:exp85|UM0129480 7μM R02 exp85]]|3.47| ^Gene^Correlation^ |[[:human genes:d:dph1|DPH1]]|0.726| |[[:human genes:d:dnajc24|DNAJC24]]|0.69| |[[:human genes:d:dph5|DPH5]]|0.685| |[[:human genes:d:dph6|DPH6]]|0.546| |[[:human genes:d:dph3|DPH3]]|0.483| |[[:human genes:e:elp6|ELP6]]|0.419| |[[:human genes:a:aar2|AAR2]]|0.409| Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|1/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4233 * **Expression level (log2 read counts)**: 6.2 {{:chemogenomics:nalm6 dist.png?nolink |}}